Background: Cubilin is a multiligand endocytic receptor necessary for early embryonic development.
Summary
Cubilin (Cubn) is a multiligand endocytic receptor critical for the intestinal absorption of vitamin B12 and renal protein reabsorption. During mouse development Cubn is expressed in both embryonic and extra-embryonic tissues and Cubn gene inactivation results in early embryo-lethality most likely due to the impairment of the function of extra-embryonic Cubn. We here focus on the developmental role of Cubn expressed in the embryonic head. We report that Cubn is a novel, interspecies conserved Fgf receptor. Epiblast-specific inactivation of Cubn in the mouse embryo as well as Cubn silencing in the anterior head of frog or the cephalic neural crest of chick embryos show that Cubn is required during early somite stages to convey survival signals in the developing vertebrate head. Surface Plasmon resonance analysis reveals that fibroblast growth factor 8 (Fgf8), a key mediator of cell survival, migration, proliferation and patterning in the developing head is a high affinity ligand for Cubn. Cell uptake studies show that binding to Cubn is necessary for the phosphorylation of the Fgf signaling mediators MAPK and Smad1. Although Cubn may not form stable ternary complexes with Fgf receptors (FgfRs) it acts together with and/or is necessary for optimal FgfR activity. We propose that plasma membrane binding of Fgf8, and most likely of the Fgf8 family members Fgf17 and Fgf18, to Cubn improves Fgf ligand endocytosis and availability to FgfRs, thus modulating Fgf signaling activity.
Cubn encodes a 460 kDa peripheral membrane protein composed of eight epidermal growth factor repeats and 27 CUB domains (Complement C1r/C1s, Urchin Egf, Bone morphogenic protein-1), which carry multiple potential sites for interaction with proteins, sugars and phospholipids (1) . Cubn is the physiological receptor for intrinsic factorvitamin B12 in the gut and for albumin in the kidney (2) . Distinct sets of mutations in CUBN either result in the Imerslund-Gräsbeck syndrome characterized by megaloblastic anemia and proteinuria (3) or in albuminuria and most-likely end-stage kidney disease (4) . Recently identified novel genetic polymorphisms in CUBN were evaluated as risk factors for neural tube defects (5, 6) . It remains to be defined whether this kind of defects is associated with the known Cubn implication in vitamin B12 homeostasis or with a novel, developmental role of Cubn.
During mouse embryonic development Cubn is expressed in various embryonic tissues as well as in the extra-embryonic visceral endoderm (7) . Cubn gene deletion perturbs the formation of both embryonic and extraembryonic derivatives including somites and blood vessels, and leads to embryo-lethality (8) . Because extra-embryonic Cubn is critical for endocytosis of various maternal-derived nutrients including high-density lipoproteins, source of cholesterol (9, 10) , the mouse knockout phenotype was essentially attributed to nutrient deficiency resulting from a deficient maternal to fetal transport (8) .
A recurrent difficulty when studying Cubn is to conciliate its endocytic function with its structure. Cubn lacks a trans-membrane domain (11) . The internalization of Cubn-ligand complexes therefore absolutely depends on the co-expression of additional proteins. We and others previously identified the trans-membrane proteins Lrp2 and Amn as endocytic partners for Cubn in the gut, kidney and extra-embryonic visceral endoderm (11) (12) (13) . Lrp2 is the only currently known Cubn partner to be also expressed along with Cubn in the early embryo (7) . In this context, it is interesting to note that lack of embryonic Lrp2 perturbs forebrain development (14, 15) and that in Lrp2 null mutants the internalization of Cubn ligands is decreased (2, 16) .
In the present study we focus on the role of embryonic Cubn during the early steps of anterior head formation. We show that Cubn is expressed in the anterior cephalic mesenchyme, cephalic neural crest cells (CNCCs) and forebrain neuroepithelium and that it is critical for cell survival and rostral head morphogenesis in the mouse, frog and chick embryos. We provide in vivo evidence that Cubn acts synergistically with Fgf8, a morphogen essential for CNCC survival, migration and proliferation and for telencephalic patterning. We identify Fgf8 as a novel Cubn ligand and show that Cubn is necessary for Fgf8 dependent phosphorylation of the Fgf targets MAPK/ERK in vitro. We furthermore provide evidence that Cubn and the Fgf8 receptor, FgfR3 functionally interact in the developing head.
Experimental procedures
Mice-Animal procedures were conducted in strict compliance with approved institutional protocols and in accordance with the provisions for animal care and use described in the European Communities council directive of 24 November 1986 (86/609/EEC). Sox2.Cre (B6.Cg-Tg (Sox2-cre) 1AmcJ) and Foxg1.Cre (129.Cg-Foxg1 tm1(cre)Skm /J) were purchased from the Jackson Laboratory (Bar Harbor, Maine).
Cubn
Lox/Lox mice (Supplemental Fig1 A, B) have previously been described (2) . The midnight before the morning with a copulation plug was considered as embryonic day 0 (E0.0). A small fragment of embryos or a piece of yolk sac was used for genotyping according to standard procedures. The absence of residual Cubn expression was confirmed by western blotting using various monoclonal and polyclonal antiCubn antibodies that detect all Cubn extracellular modules, i.e. both EGF-and CUBdomain regions (Supplemental Fig. 1C) . In situ RNA hybridization-Heart-beating embryos were fixed and analyzed by wholein situ RNA hybridization according to standard procedures. Simultaneous detection of cell death and proliferation-Lyso Tracker Red (Invitrogen, DND99, Eugene, OR) staining was previously described (17) . For cell proliferation antiphospho-Histone H3 (1:250, Millipore, Molsheim, France) followed by Alexa 488-conjugated goat anti-rabbit (1:200, Invitrogen) was used. Nuclear staining was achieved by 20 min incubation in Hoechst 33342 (Invitrogen). Images were collected by confocal microscopy (LSM710 ConfoCor 3, Carl Zeiss) and processed using ImageJ software. Total numbers of lysotracker-and pH3 positive profiles were counted in 15 and 23 consecutive sections for E8.75 and E9.25 embryos respectively; in some cases 4 consecutive medial or more superficial sections were used. Immunocytochemistry and vital staining-Fixed whole embryos or frozen sections (10 μm thick) were processed for immunocytochemistry using rabbit anti-Cubn (1:1,000), sheep anti-Lrp2 (1:4,000), rat anti-PECAM1 (1:75; BD Pharmingen), or rabbit-anti-Tfap2a (1:100; Santa-Cruz) antibodies. In some cases frozen sections were counterstained with Nissl (Sigma). Protein analysis-Embryos and subconfluent cells were lysed in a PBS buffer containing 10 mM NaH 2 PO 4 , 150 mM NaCl, 6 mM CaCl2, 1% Triton X-100, 1mM Na 3 VO 4 (Sigma), and Complete mini EDTA-free protease inhibitor cocktail tablets (Roche Diagnostics), 2 mM sodium orthovanadate and phosphatase inhibitor cocktail 1 (Sigma). For western blot analysis 10 g total protein was applied to each well. Equal loading was verified by blotting for Gapdh. Primary antibodies used: rabbit anti-P-Akt (Ser473; 1:1,000; Cell Signaling), total anti-Akt (1:1,000; Cell Signaling), goat anti-BMP7 (1:3,000; Abcam), goat anti-b-catenin (1:500; Santa-Cruz, C-18), mouse anti-P-b-catenin (1:500; Santa-Cruz, 1B11), rabbit anti-cleaved caspase 3 (1:2,500; Cell Signaling, 9661), goat anti-chordin (1:500; Santa-Cruz, V-18), mouse anti-Cubn (1:4,000) (18) rabbit anti-cubn (1:5,000), rabbit anti-PErk1/2 (Thr202/204; 1:1,000; Cell Signaling), rabbit anti-Erk1/2 (1:1,000; Cell Signaling), mouse anti-Fgf2 (1:500, Santa-Cruz), mouse anti-Fgf3 (1:500; Santa-Cruz, MSD1), goat antiFgf8b (1:1,000; AF423-NA, R&D systems), mouse anti-Fgf8b (1:1,000; MAB323, R&D systems), rabbit anti-Fgf8 (1:500, 7916, Santa Cruz), goat anti-Fgf15 (1:500; Santa-Cruz, P-20) , mouse anti-Fgf17 (1:500, Santa-Cruz, B-4) and goat anti-Fgf17 (1:500, Santa-Cruz, C-14), rabbit anti-FgfR1 (1:1000; 52153, Abcam), rat anti-FgfR2c (1:1,000; MAB716, R&D systems), mouse anti-FgfR3c (1:1,000; MAB7662, R&D systems), rabbit anti-Noggin (1:500; Santa-Cruz, Fl-232), rabbit anti-PSmad1 (Ser206; 1:1,000; Cell Signaling), rabbit anti-Smad1 (1:1,000; Cell Signaling), rabbit anti-PSmad1/5/8 (1:1,000; BD-Pharmingen), rabbit anti-Wnt1 (1:500; Santa-Cruz, H-89), rabbit anti-Wnt3 (1:500; Santa-Cruz, H-70), and goat anti-Wnt8b (1:500; Santa-Cruz, 25177). Morpholino oligonucleotide design and injection in X. Laevis eggs-Embryos were obtained as previously described (19 20) . The anterior neural plate was dissected out. The embryo was further dissected into truncal and caudal halves. Batches of 6 explants were processed for RNA extraction using RNeasy kit (Qiagen SA). One µg of total RNA was used for reverse transcription (Applied Biosystems, Carlsbad, CA). Quantitative RT-PCR was performed using Fast SYBR Green Master Mix (Applied Biosystems). Cell culture-Brown Norway Rat yolk sac epithelial cells transformed with mouse sarcoma virus (BN/MSV) were grown as previously described (18) . BN/MSV cells were seeded in 24-well plates and used at subconfluence. Overnight serum-starved cells were incubated for five min with 5ng/ml Fgf8b (cat 423-F8, R&D systems, Minneapolis, MN) or 5ng/ml heparin stabilized FGF2 (F9786; Sigma). Recombinant Cubn fragments expressing CHO cells were previously described (20) . SPR analysis, immunoprecipitation-SPR analysis was performed on a Biacore 3000 as previously described (21 Control immunoprecipitation was performed with rabbit or mouse preimmune serum. All precipitated proteins were analyzed by reducing SDS-PAGE and were detected by autoradiography using ECL reagents as described by the manufacturer (GE Healthcare). Functional assays in avian embryos-dsRNA were synthesized from cDNA encoding for the targeted genes: dsCubn1 (nts:581-883, exons 7-8), dsCubn2 (nts:6680-7034, exons [44] [45] , dsFgfR1 (nts:605-891, exons 5-7), dsFgfR2 (nts:785-1106, exons 5-6), dsFgfR3 (nts:612-927, exons 6-7). In ovo electroporation was performed as previously described (22) . Briefly, electroporation in the developing head was performed in chick embryos at 5 to 6 somites stage (5-6ss, i.e. 30 hours of incubation at 37°C). Exogenous nucleic sequences dsCubn, dsFgfR1, dsFgfR2, dsFgfR3 or combinations (200ng/µl), and RCAS-Noggin were mixed in a solution of Fast Green FCF (0.01%, Sigma), bilaterally transfected to the cephalic NC cells or transfected to the cephalic NC cells and cephalic ectoderm. For control series, non-annealed sense and antisense RNA strands corresponding to the sequences of the targeted genes were transfected at the same concentrations. The efficiency of the silencing was confirmed by in situ hybridization analysis. For protein supplementation, heparin-acrylic beads (Sigma) soaked with a solution of Fgf8b recombinant protein (5µM; R&D systems) were used. Statistical analysis and graph plotting-Sigmastat (Systat Software Inc., Richmond, CA, USA) was used for data analysis. Excel (Microsoft) was used to plot data.
Results
Cubn is expressed in the cephalic neuroepithelium and neural crest cells during early somite stages. In pre-somitic stages Cubn mRNA is strongly expressed in the extraembryonic visceral endoderm (Fig 1A-C and (7)). During neurulation (E8.5, 5-7 ss,) Cubn mRNA is found in the prospective forebrain neuroepithelium, the optic eminences and the cephalic mesenchyme (Fig 1D, E) . Cubn immunostaining reveals that Cubn is distributed at the apical pole (23)of the neuroepithelial cells (Fig 1F-H , J) as well as along the plasma membrane of cells adjacent to the cephalic neural folds and the surface ectoderm ( Fig 1G, I -L). At E9.0 (13-16 ss,) Cubn mRNA and protein are readily detected in the ventral forebrain and pharyngeal regions and at low levels in the mesenchyme of the dorsal forebrain, mid-and hindbrain (Fig 1M, N) . Double immunostaining for Cubn and the neural crest marker Tfap2 shows that Cubn is partly expressed in Tfap2 positive CNCCs (Fig 1N-P) . In these cells Cubn is also co-expressed with Lrp2 (Fig 1 Q- 
S).
Sox2-Cre mediated ablation of embryonic Cubn leads to rostral head hypoplasia by E9.5. To inactivate embryonic Cubn we used a floxed Cubn allele (Supplemental Fig. 1A , B) and and the Sox2-Cre transgene. Whereas the maternally inherited transgene recapitulates the null phenotype (Supplemental Fig. 1C -M) as previously reported (8), the paternally inherited Sox2-Cre transgene that we used here, induces recombination only in epiblast cells from E6.5 onwards (24) and leads to inactivation of Cubn in both the neuroepithelium and the mesenchyme (Supplemental Fig. 1N -S). CubnL/+;Sox2-Cre heterozygous mice were viable and morphologically normal. CubnL/L; Sox2-Cre (hereafter designed as Cubn Sox2-Cre-KO ) mutants did not develop beyond E12.5 (Table 1) . At E8.5 ( Fig. 2A, 2A' ) the morphology of the Cubn Sox2-Cre-KO mutants was similar to that of the controls. From E9.5 (~25 ss) onwards and despite the apparently normal body axis and heart formation the forebrain, in particular the telencephalon was markedly reduced in size (33% compared to the controls, n=7) and the optic vesicles were hypoplastic or absent ( Fig.  2B-F' ). Despite the reduction, the general prosomeric organization of the mutant forebrain was preserved until E10.5 ( Fig. 2D, D' ).
To find out whether Cubn is necessary in the early forebrain neuroepithelium we used the Foxg1-Cre allele widely expressed in the forebrain and the facial ectoderm around E9.0 (25) . Despite Cubn deletion, residual Cubn immunostaining was still detectable in the telencephalon of E10.5 CubnL/L;Foxg1-Cre mutants. Telencephalic development was normal in these mutants and only minor cortical defects, including the absence of corpus callosum could be evidenced at later stages (Supplemental Fig.  2 ). We therefore focused on the Cubn Sox2-Cre-KO mutants.
Forebrain and face hypoplasia in E9.25 Cubn Sox2-Cre-KO mutants correlates with decreased cell survival.
At E9.25 (~20 ss), prior to the appearance of major telencephalic hypoplasia, cell proliferation evidenced by the M-phase cell cycle marker phospho-histone H3 (PH3) was not modified in the cephalic region of Cubn Sox2-Cre-KO mutants (Fig. 3A, A' , B and Supplemental Fig.  3A-B' ). However cell death, followed by the fluorescent dye Lysotracker (26), was significantly increased in the anterior mutant head (Fig. 3A, A', C), both in the ventral and dorsal cephalic mesenchyme (Supplemental Fig.  3A , A'). At this stage Lysotracker staining was marginal in the telencephalic neuroepithelium (Supplemental Fig. 3B, B' ). Immunoblotting of E9.25 anterior cephalic extracts showed increased expression of activated caspase-3 in the mutants (Supplemental Fig. 3C ) indicating enhanced apoptosis.
Forebrain patterning is maintained in E9.25 Cubn
Sox2-Cre-KO mutants.
We next performed a detailed molecular analysis of the forebrain. Regional specification of the forebrain is controlled by at least three signaling centers that work synergistically and regulate each other (27) (28) (29) (30) (Fig. 3D-F' ). The occupancy percentage of Foxg1 in the telencephalon was identical in the mutants and wild-type littermates (35% versus 33% respectively, n=4) indicating that the reduction of the Foxg1 expression domain was due to the hypoplasia of the forebrain. Similarly, the expression domain of Six3 was reduced in the mutant hypoplastic rostroventral telencephalon and optic vesicles (Fig. 3G, G' ). Shh was absent from the mutant preoptic area only (Fig. 3H, H' ) and Nkx2.1, which is necessary in the ventral forebrain for the activation of Shh, was also absent from the preoptic area but remained normal in the hypothalamus (Fig. 3I, I' ). Spry1, an Fgf signaling antagonist was present in the mutant commissural plate and isthmus but did not expand ventrally in the ventral cephalic ectoderm (Supplemental Fig. 3D, D' ). Emx2 along the dorsal telencephalon (Fig. 3J, J' ) and Bmp7 at the dorsal midline were similarly expressed in the wild-type and mutant embryos (Supplemental Fig. 3E, E') . Finally, the diencephalic marker Wnt8b was normally expressed in the mutants and En2 was normally detected at the diencephalic-mesencephalic boundary (Supplemental Fig. 3F-G') . The above data show that, despite the strong reduction of the forebrain tissue and the discreet patterning defects, forebrain organization is maintained in the Cubn Sox2-Cre-KO mutants.
Abnormal distribution of CNCCs contributes to head defects in Cubn
CNCC is a migratory population that derives from the dorsal fore-, mid-and hindbrain and contributes to head morphogenesis. The survival, migration and patterning of CNCCs require signals of the previously cited patterning centers (31) (32) (33) .
The rostroventral expression of the CNCC markers Tfap2 and Dlx2 was patchy at the level of the mutant telencephalon and in the periocular region. These markers were normally expressed in the first BA (Fig. 3K-L') . The ectodermal and CNCC marker Dlx5 was decreased rostrally at the level of the mutant telencephalic region but remained expressed in the ventral most cephalic ectoderm and BA region (Fig. 3M, M' ). Thus, around E9.25, a stage at which in wild-type embryos the spread of the CNCC over the forebrain and first BA region is complete, the distribution of representative CNCC markers is abnormal in the mutants suggesting that defective migration and/or survival of the CNCC in the rostral head contributes to the cephalic hypoplasia in the Cubn Sox2-Cre-KO mutant embryos.
Normal forebrain regionalization and perturbed Fgf signaling in E8.75 Cubn
Sox2-Cre-KO mutants. In order to identify the onset of the defects we analyzed mutant embryos at earlier developmental stages. We could not see any alteration in the expression of the early anterior neuroectoderm and rostrolateral ectoderm markers Otx2, Dlx5, Hesx1 and Six3 (Supplemental Fig. 4A-D' ) between E7.5 and E8.25 and Fgf8 was normally induced at the mutant anterior neural ridge (ANR), prospective rostral patterning center, at E8.25 (Supplemental Fig.4E , E') indicating that forebrain specification was normally initiated in the mutants. At E8.75 (8-10 ss) the Cubn Sox2-Cre-KO mutants were phenotypically normal. The rates of cell proliferation and cell death were similar in the forebrain and surrounding tissues of E8.75 mutant and wild-type littermates (Fig. 4A, A' , Supplemental Fig. 5A-B) . Fgf8 was maintained in the mutant ANR (Fig. 4B, B',) and Foxg1 expression similarly marked the mutant ANR and neuroectoderm (Fig. 4C, C' , Supplemental Fig. 5C-D' ). The expression of the BMP antagonist-encoding Noggin and of Bmp7 was unaffected in the mutant axial mesendoderm (Fig. 4D, D', Supplemental Fig. 5E , E'). Bmp4 was not ectopically expressed in the mutants (Supplemental Fig. 5F , F'). Wnt1 and Wnt8b were normally distributed in the presumptive diencephalon and midbrain (Fig. 4E-F') . Shh was unaffected in the mutant neuroectoderm and axial mesendoderm (Supplemental Fig. 5G , G') and Gli1, whose transcription is absolutely dependent on Shh signaling was normally expressed in the mutant ventral forebrain (Supplemental Fig. 5H, H' ). Six3, a repressor of Wnt1 and Wnt8b (34, 35) and an activator of Shh, appropriately marked the developing mutant ventral forebrain and eyes (Supplemental Fig. 5I, I') . Finally, the early CNCC and ectodermal markers Tfap2Msx1, Dlx5 and Dlx2 were normally distributed at the dorsal neural folds of the mid-, and hindbrain and in the cephalic ectoderm ( Fig. 4G-H' , Supplemental Fig. 5J-K') . Noggin was also normally detected along the dorsal neural folds and in the lateral cephalic mesenchyme of the mutants (Fig. 4I,  I To understand why despite normal neuroepithelial and neural crest marker expression at E8.75, increased apoptosis and perturbed CNCC distribution were evidenced half a day later in the mutants we investigated whether the main signaling pathways involved in anterior cell survival, early forebrain regionalization and global head morphogenesis were active (36) (37) (38) . We analyzed the phosphorylation of the known Tgf- Wnt and Fgf signaling effectors in anterior cephalic extracts of E8.75-E9.0 control and mutant embryos. Similar expression levels of Phospho Smad1/5/8 and Phospho Smad2 suggested that the intensity of Tgf- activity was unaffected in the mutants (Fig. 4J) . Wnt signaling-dependent GSK3 and Fgf/MAPK/ERK activities modulate the duration of the Bmp signal by catalyzing phosphorylation of Smad1 in the linker region, predominantly at Ser206 (39, 40) . We could not detect Smad1 phosphorylated at Ser206 in the mutants (Fig. 4J) . As suggested by the similar levels of -catenin and phosphorylated -catenin in control and mutant extracts (Fig. 4J) , this was not due to modified Wnt, and presumably GSK3 activity.
We therefore analyzed the phosphorylation of ERK1/2 which mediates intracellular responses downstream to Fgf/FgfR signaling in the anterior head (41, 42) and triggers linker phosphorylation of Smad1 (39) . The levels of ERK1/2 were clearly decreased in the mutant extracts (Fig. 4K) suggesting decreased Fgf activity. However, the unaltered levels of phospho-Akt, another Fgf effector in the anterior head (Fig. 4K) , and of FgfR1-3 indicated that Fgf signaling was at least partly, operating in the mutants, a finding consistent with the normal forebrain patterning. Taken together these results support the idea that in E8.75-9.0 Cubn Sox2-Cre-KO mutants the prosurvival Fgf signals may be not efficient enough to limit the duration of the pro-apoptotic Bmp activity, eventually contributing to increased anterior cell death and head hypoplasia.
The high affinity binding of Fgf8 to Cubn leads to efficient ERK1/2 and Smad1 linker phosphorylation. To understand how Cubn may affect the Fgf signaling pathway we sought for potential interactions between Cubn and Fgf8, the best studied Fgf ligand during head morphogenesis. Fgf8 as well as the Fgf8-subfamily member, the structurally similar Fgf17 (43) were co-immunoprecipitated with Cubn in anterior cephalic extracts of wild-type E8.75-9.0 embryos (Fig. 5A) . Structurally distinct Fgfs, including Fgf2 and the ANR produced Fgf3 and Fgf15 were not coimmunoprecipitated with Cubn. Similarly, neither Wnt1, Wnt8b, Wnt3, Bmp7 nor Noggin were detected in the immunoprecipitates (Supplemental Fig. 6A ).
Further surface-plasmon resonance (SPR) analysis showed that recombinant mouse Fgf8a and Fgf8b, the two biologically active Fgf8 isomorphs (44, 45) , bound in a Ca 2+ -dependent manner and with equally high affinity to a purified Cubn chip (Fig. 5B) . The dissociation constant (Kd) was calculated to 20 nM, a value orders of magnitudes higher than those reported for binding of Fgf8b and Fgf8a to their established receptors (Kds ~126-492 nM and 1-2.5 mM, respectively) (45) . The equally high affinity of Fgf8a, the shorter Fgf8 isoform, and Fgf8b for Cubn indicated that the binding site of Fgf8 to Cubn was localized in the common core of the Fgf8 isoforms. Binding of Fgf8a or Fgf8b to Cubn was neither enhanced nor inhibited by recombinant FgfR1 or FgfR2 (Supplemental Fig. 6B ) indicating i) that the binding sites of Fgf8 to Cubn and to FgfRs are distinct, ii) that FgfRs and Cubn do not directly interact and iii) that Cubn, Fgf8 and FgfRs do not form ternary complexes. Fgf8b did not bind to a control chip with the molecular partner of Cubn, Lrp2 (14) . A very low affinity in the micromolar range was recorded for recombinant mouse Bmp7, which interacted also with the control Lrp2 chip.
To further characterize the interaction between Cubn and Fgf8 we incubated Fgf8b with overlapping recombinant Cubn constructs encoding the CUB domains 1-8, 7-14, 13-20 and 19-27 (20) . Immunoprecipitation with sepharose-bound anti-Cubn and anti-Fgf8b antibodies identified CUB domains 1-8 and 7-14 as the ones to be most likely involved in the interaction with Fgf8b (Fig. 5C) .
To distinguish between FgfR-mediated and Cubn-assisted internalization of Fgf8 and verify that internalization of Cubn-bound Fgf8 results in the phosphorylation of ERK1/2 and Smad1 linker we incubated Cubn expressing BN/MSV cells (46) with recombinant Fgf8b for five minutes without the addition of heparin, a component required for Fgf ligand binding to FgfRs (47) . As a control of Cubn-independent FgfR activation, we in parallel incubated BN/MSV cells with recombinant heparin-bound Fgf2. Phosphorylation of ERK1/2 and Smad1 linker was first detectable five minutes after addition of Fgf8b or Fgf2-heparin and was sustained over the time of the experiment, i.e. 60 min (Fig. 5D) . In Fg8b-treated cells endocytosis blocking anti-Cubn antibodies (18) or bioactivity neutralizing anti-Fgf8b antibodies (100g/ml) prevented the phosphorylation of both ERK1/2 and Smad1 linker (Ser206) whereas control IgG had no effect (Fig. 5D ). In contrast, in Fgf2-heparin treated cells the phosphorylation of neither ERK1/2 nor Smad1 linker was modified by anti-Cubn antibodies. These results demonstrate that Fgf8 is a specific high affinity ligand of Cubn and that Cubn-assisted Fgf8 internalization results in Fgf8 signaling.
We then wondered whether Cubn and Fgf8 co-operate during head morphogenesis in vivo and whether Cubn expressed in the CNCCs is involved in the CNCC-Fgf8 cross-talk, a process critical for the formation of the cephalic vesicles (33, 48, 49) . We failed to obtain mouse mutants lacking both Cubn and Fgf8 in the epiblast and to inactivate Cubn in the neural crest cells, including the rostral most CNCC population using mice expressing Crerecombinase under the control of Wnt1 cisregulatory elements. We therefore continued our study using frog and chick embryos.
Synergistic interplay between Cubn and Fgf8 during head formation. Quantitative RT-PCR analysis showed that XCubn mRNA was enriched in the anterior neural plate region of neurula stage frog embryos and this was confirmed at the protein level (Supplemental Fig. 7A, B) . We selectively depleted Cubn in the left side of the head by microinjecting translation-blocking antisense morpholino nucleotides into the left dorso-animal blastomere of 8-cell stage embryos (Supplemental Fig. 7C ). The expression of XFgf8 in the ANR and the isthmus was maintained independently of the morpholino used (Fig. 6A, A' ). However, they both led to reduction of the expression domains of XFoxg1 (Fig. 6B, B' ) and XOtx2 (Fig. 6C,  C' ) as well as to hypoplasia of the telencephalic and eye vesicles (Fig. 6D and Supplemental Fig.  7D ). Western blot analysis of treated embryos showed increased levels of activated caspase-3 ( Fig. 6E) indicating that hypoplasia was accompanied by enhanced apoptosis.
Forebrain hypoplasia and reduced Foxg1 expression were as expected, also observed after depletion of XFgf8 (Fig. 6F) (Fig. 6G,  H ). Combined these morpholinos induced severe telencephalic hypoplasia and complete downregulation of XFoxg1 in two independent experiments and in 24 out of 27 doubly-injected embryos (Fig. 6I, J and Supplemental Fig. 7E ). These results support the idea that XCubn and XFgf8 act synergistically during head morphogenesis. Cubn is required for CNCC survival and head formation. In the chick embryo, before CNCC migration, at the 5 ss, Cubn is detectable at low levels in the cephalic ectoderm (CE) flanking the ANR region and in the neural folds at the level of the prospective fore-, mid-and rostral hindbrain, i.e. the presumptive CNCC (Supplemental Fig. 8A, B) . After neural tube closure and CNCC migration Cubn remains restricted to the prospective anterior CE, rostroventral forebrain and post-migratory CNCC (Supplemental Fig. 8C-E) .
We silenced endogenous Cubn specifically in the cephalic neural folds or in both the cephalic neural folds and the anterior CE by electroporating dsCubn mRNA at the 5 ss, before the onset of CNCC migration. Twenty-four hours later, i.e. at the 25 ss, and independently of the experimental design used head morphogenesis was severely affected (Fig.  7A-B', 7G-H') . Although the neural tube remained closed, the fore-and midbrain vesicles failed to expand and the head volume was reduced by 42% in the treated embryos compared to the controls (n=10). Despite the by guest on November 18, 2017 http://www.jbc.org/ Downloaded from reduction of the expression domains of Foxg1 (Fig. 7C, C', I ) and Otx2 (Fig. 7D, D', J) silencing of Cubn did not affect fore-or midbrain patterning and Fgf8 was readily detected in the ANR and isthmus (Fig. 7E, E') .
We noted that the decrease in head size correlated with extensive cell death, observed mainly in the cephalic mesenchyme a few hours after Cubn silencing, i.e. at the 18 ss, (Fig. 7F,  F' ). To verify that Cubn expressed in the migratory CNCCs functions, either directly or indirectly to regulate cell survival we overexpressed the survival factor Noggin, a CNCC produced factor known to potentiate Fgf8 signaling by counteracting Bmp activity (22) , in the Cubn-depleted CNCCs. Over-expression of RCAS-Noggin in the CNCCs rescued the morphological defects and allowed normal foreand midbrain formation (Fig. 8A-A'' ). These results indicate that Cubn expressed in the migratory CNCCs is necessary for cell survival most likely by regulating CNCC response to Fgf8 signals.
We next sought to identify the FgfRs involved in Fgf8 signal reception in the CNCCs and document the potential interactions between Cubn and FgfRs in vivo. FgfR3, FgfR1 and to a lesser extent FgfR2 are expressed in the presumptive CNCCs and CE (50, 51) in a pattern similar to Cubn. Silencing of FgfR3 at the 5 ss resulted in fore-, midbrain and facial hypoplasia (Fig. 8B-C' ) although less severe than the ones seen in dsCubn treated embryos (Fig. 7G-H' ) whereas electroporation with dsFgfR1 or dsFgfR2 did not affect head development (Fig. 8B''-C''' ). We therefore further focused on FgfR3 and Cubn and depleted the CE and cephalic neural folds from both Cubn and FgfR3. This double Cubn-FgfR3 silencing aggravated the individual phenotypes and lead to cephalic aplasia (Fig. 8D-D'' ) and lethality the day following the electroporation. This set of results shows that in the chick embryo FgfR3 is critical for Fgf, including Fgf8, signaling in the head and provides evidence that Cubn acts synergistically with FgfR3 in the CNCC and CE to convey signals for anterior cell survival and head morphogenesis (Fig. 8E) .
Discussion
In this paper we identify a novel developmental role of embryonic Cubn in the vertebrate head. Ablation of embryonic Cubn leads to head hypoplasia that correlates with increased anterior cell death, abnormal distribution of migratory CNCCs and decreased expression of phosphorylated ERK, events that may be explained by deficient Fgf signaling. High affinity binding of Fgf8 to Cubn leading to ERK phosphorylation as well as synergistic function between Cubn and Fgf8 in the anterior head and Cubn and FgfR3 in the migratory CNCC and CE support our conclusion that Cubn may act as an extracellular modulator of Fgf8 signaling during head morphogenesis.
Cubn expressed in the cephalic neural crest is necessary for head morphogenesis but not patterning.
During early somitic stages murine Cubn is expressed in the forebrain and the cephalic neural folds. After neural tube closure Cubn remains detectable in the neuroepithelium and in the cephalic mesenchyme but is excluded from the cephalic ectoderm. Partial colocalization with Tfap2 indicates that Cubn is expressed in the migratory CNCCs. At later developmental stages Cubn is also expressed in various tissues of endodermal and mesodermal origin (7) .
The epiblast-specific inactivation of Cubn resulting in efficient ablation of embryonic Cubn shows that Cubn is critical for head morphogenesis but does not allow the unambiguous identification of the embryonic tissues at the origin of the head defects. Several lines of evidence indicate however that mesodermal and endodermal development are normal in Cubn Sox2-Cre-KO mutants at least until E9.5 and that the cephalic hypoplasia is neither the consequence of a developmental arrest nor of a heart defect: a) The induction and maintenance of the anterior and forebrain identity as evidenced by Otx2, Hesx1, Six3 and Fgf8 in situ hydrization are not modified in the mutants; b) somite and body axis formation and turning onset around the 8-10 somite stage occur normally; c) at the same stage, the expression of Bmp7 in the mutant embryonic heart region is normal; d) a normal beating heart lying posterior/ventral to the head is seen until E9.5; e) PECAM-1 immunocytochemistry which is routinely used to detail embryonic vasculature clearly detects well developed blood vessels at the level of the forebrain at E9.5. It is thus unlikely that a cardiovascular system failure or a delayed growth may explain the cephalic hypoplasia of the mutants.
Combined the results obtained in the mouse, frog and chick embryos show that the head hypoplasia is neither due to defective patterning indicating that Cubn is not absolutely required for this process. In the mouse embryo, the lack of Shh and Nkx2.1 specifically in the preoptic area is the only forebrain defect at E9.25. This defect previously described in Fgf8 hypomorphs (52) Furthermore Cubn remained detectable in the CNCC of the rostral most forebrain region of Cubn Wnt1-Cre-KO mutants. XCubn silencing in the anterior head of the frog embryo provided the first direct indication that Cubn was necessary for head morphogenesis. It is the use of the chick embryo that allowed us to clearly define that CNCC is the most important site of Cubn expression/function during head morphogenesis.
CNCC is considered as a signaling center critical for neural tube closure and normal cephalic vesicle formation (22, 33) . In both mouse and chick, the cephalic neural crest has a double function: it responds to Fgf8 survival, proliferation and migration signals and maintains Fgf8 expression and signaling from the ANR by secreting Bmp antagonists (31) (32) (33) 
Cubn and Fgf8 counteract pro-apoptotic Bmp activity.
Fine-tuning of the equilibrium between Bmp, Wnt and Fgf pro-and anti-apoptotic activities depends on the phosphorylation of the main Bmp effector Smad1 (40) . Bmps promote C-terminal phosphorylation of Smad1/5/8, which is required for Bmp signaling (40) . This process is identical in E8.75 wild-type and Cubn Sox2-Cre-KO mutant embryos indicating that the intensity of the pro-apoptotic Bmp signal is not modified and that retinoic acid activity which suppresses Bmp activity by promoting degradation of C-terminal phosphorylated Smad1 (54) is normal. On the anti-apoptotic side, Fgf/MAPK and GSK3 mediate two sequential phosphorylations of the Smad1 linker region, which limit the duration of the Bmp signal (39, 55 How this cooperation occurs at the cell level is not known. The sub-cellular distribution of FgfRs in vivo has not been reported extensively in the developing brain but cell surface availability may be low (42) . Gutin et al (56) postulated the existence of extracellular and/or intracellular modulators that would impart specificity in Fgf-responsiveness. In this context, Cubn, which binds to the core region of Fgf8 with high affinity could "focus" members of the Fgf8 family to specific cell types, including the CNCC, and allow internalization of Fgf8 independently of FgfRs. Our data support this hypothesis; Cubn does not interact with FgfR1 or FgfR2 in vitro and because of structural similarities, most likely with the other FgfRs (57) .
To behave as a distinct Fgf8 receptor Cubn, which has no cytoplasmic domain, needs to interact with a transmembrane protein. Amn, a molecular partner of Cubn in the visceral endoderm and other absorptive epithelia, is hardly detectable in the neuroepithelium and not detectable in the CNCC. It is therefore unlikely that Amn is important for Cubn function in the anterior head. In agreement with that Amndeficient chimeras are viable (58). We propose that Lrp2, the other known endocytic partner of Cubn, expressed in the neuroepithelium and CNCC may at least partly facilitate endocytosis of Cubn-bound Fgf8. However because the phenotype of the epiblast-specific Lrp2 mutants is milder (15) than that of Cubn mutants it is likely that Cubn interacts with additional yet not identified transmembrane proteins in the developing head.
Finally, polymorphisms in CUBN were proposed to be risk factors for neural tube closure defects (5, 6). We cannot exclude that this type of defects may be due to inadequate B12 levels in the mother or the foetus. However NTDs are not associated with the selective vitamin B12 malabsorption Imerslund-Gräsbeck syndrome (59) and the maternal-to-fetal transport of vitamin B12 does not involve CUBN. Neural tube closure was not modified after selective Cubn ablation in the animal models and at the stages analyzed here. However somite and body axis formation is severely perturbed in Cubn null mice (8) . In view of our data it is tempting to propose that the above polymorphisms may selectively modify the binding capacities of Cubn for Fgf8 family members during very early developmental stages and affect in addition to CNCC, other Fgf8 responsive tissues involved in neural tube closure such as the mesoderm.
In conclusion, Cubn is a novel receptor for Fgf8 and most likely the Fgf8-subfamily members Fgf17 and Fgf18, necessary for efficient FgfR signaling and cell survival during early head morphogenesis at least in the mouse, frog and chick embryos. We propose that Cubn may favor FgfR activation by increasing Fgfligand endocytosis/availability in all Cubnexpressing tissues. Control IgG has no effect. Endogenous Smad1 and Erk1/2 levels are shown for comparison and GAPDH is used as loading control. 
FIGURE 7.
Cubn expressed in the CNCC is critical for chick head formation. A-B'. Electroporation of dsCubn in the premigratory CNCC leads to severe cephalic (arrow points to the telencephalon) at E2 (A, A') and E4 (B, B'). C-E'. Representative whole-mount mRNA staining for Foxg1, Otx2 and Fgf8 in control (C-E) and dsCubn-treated (C'-E') embryos. Silencing of Cubn in the CNCC leads to decreased Foxg1 (C, C') and Otx2 (D, D') expression domains in the telencephalon whereas Fgf8 (E, E') remains expressed in the ANR. F, F'. Lysotracker staining at ~ E1.5 shows enhanced cell death in the head at the level of the rostral forebrain (thick arrow), the lateral (asterisk) and the ventral cephalic mesenchyme (arrow) of a dsCubn treated embryo. G-H'. Silencing of Cubn in the premigratory 
